Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

620
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
620
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

932
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
932
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
452
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

876
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

469
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
469
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

735
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
735

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Imaging and Molecular Biomarkers of PFAS-Related Vascular Aging: A Narrative Review.

International journal of molecular sciences·2026
Same author

Per- and Polyfluoroalkyl Substances Exposure and Ischemic Heart Disease: Emerging Evidence from the Literature.

Antioxidants (Basel, Switzerland)·2026
Same author

Genetic Polymorphisms as Key Modulators of Cardiovascular Risk from Endocrine-Disrupting Chemicals.

Genes·2026
Same author

Vascular Aging and Atherosclerosis: The Modulatory Impact of Selenium-A Comprehensive Review.

Cells·2026
Same author

Oxy-Inflammatory Profile of Finishers and No-Finishers in an Extreme Ultra-Endurance Trail Race: The 866 km Transpyrénéa.

International journal of molecular sciences·2026
Same author

Genetic Polymorphisms as Modifiers of Health Risks from Exposure to Toxic Elements: A Traditional Literature Review.

Toxics·2026

相关实验视频

Updated: Jan 10, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K

:在炎症性肠病中的一个关键元素.

Francesca Gorini1, Alessandro Tonacci1

  • 1Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy.

Antioxidants (Basel, Switzerland)
|November 27, 2025
PubMed
概括

(Se) 由于其抗氧化和抗炎性质,在控制炎症性肠病 (IBD) 中起着至关重要的作用. 这篇评论探讨了SeSe.

科学领域:

  • 胃肠道学和免疫学

背景情况:

  • 炎症性肠病 (IBD) 是一种复杂的胃肠道疾病,其特点是慢性炎症,氧化应激和免疫失调.
  • IBD的病因是多因素的,涉及遗传学,免疫反应,肠道微生物群和环境因素,其全球流行率正在上升.
  • 在IBD患者中,营养不良很常见,这促使人们对 (Se) 等微量营养素在疾病调节中的作用进行研究.

研究的目的:

  • 综合审查目前的证据,将状态与炎症性肠病联系起来.
  • 阐明影响IBD病变的生物机制.
  • 引入纳米颗粒作为IBD管理的潜在治疗策略.

主要方法:

  • 对和IBD的流行病学研究和实验发现的系统审查.
  • 分析的生理功能,包括抗氧化,抗炎和免疫调节作用.
  • 探索对肠道微生物组成和多样性的影响.

主要成果:

  • 是一种重要的微量元素,具有与IBD相关的显著抗氧化和抗炎性质.
  • 有证据表明,状态和IBD活性之间存在关系,其介于其对氧化应激和免疫反应的影响.
  • 会影响肠道微生物群,可能会影响IBD的发病性.

结论:

关键词:
克罗恩氏病是什么 克罗恩氏病是什么我们的肠道微生物群.免疫系统 免疫系统这是一种炎症炎症炎症炎症.炎症性肠病是一种炎症性肠病.纳米颗粒是一种纳米粒子.氧化应激是一种氧化应激.是一种.单蛋白质是一种单蛋白质.性结肠炎是一种

更多相关视频

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.7K

相关实验视频

Last Updated: Jan 10, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

68.7K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.5K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.7K
  • 的状态是炎症性肠病的一个重要因素.
  • 的多方面的生物活动为IBD提供了治疗潜力.
  • 纳米颗粒代表了IBD治疗的有前途的新方法.